Cirrhosis News and Research

Latest Cirrhosis News and Research

Long-term intake of sunflower, fish oils affects the liver

An international group of scientists led by the University of Granada (UGR) has demonstrated that the long-term intake of sunflower or fish oils damages the liver and can cause a series of alterations in it, giving rise to non-alcoholic steatohepatitis.

31 Jan 2018

UT Southwestern oncologist highlights need to improve liver cancer screening rates

Patients with cirrhosis should be screened regularly for liver cancer, though few are – in part because busy physicians often don't order the screening tests, said UT Southwestern oncologists.

30 Jan 2018

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

A new Practice Guideline and Practice Guidance in Hepatology will help improve the diagnosis and treatment of patients with liver cancer as well as patients with non-alcoholic fatty liver disease (NAFLD), which can lead to liver cancer and is characterized by the build-up of extra fat in liver cells often due to obesity and diabetes.

27 Jan 2018

Drinking during late adolescence could be first step to liver problems in adulthood

Alcohol is the leading cause of liver cirrhosis and liver-related deaths. Results of a large long-term study in Sweden have confirmed that drinking during late adolescence could be the first step towards liver problems in adulthood and that guidelines for safe alcohol intake in men might have to be revised downwards, reports the Journal of Hepatology.

22 Jan 2018

Alcohol related ER visits on the rise especially among women, finds study

According to a recent study, there is a steady rise in the number of individuals visiting the emergency rooms due to complications and problems associated with alcohol consumption over the last few years. The results of the new study appeared in the latest issue of the journal Alcoholism: Clinical and Experimental Research.

11 Jan 2018

Emerging pharmacologic approach may inhibit NASH

Treating a liver disease called NASH (non-alcoholic steatohepatitis), which affects 10 to 15 percent of obese individuals with type-2 diabetes worldwide, is difficult. But now scientists believe they have found a pharmacologic approach that may inhibit NASH, and thus stop deadly conditions that result from NASH such as cirrhosis and liver cancer.

21 Dec 2017

Unique liver function of South American amphibian could pave way for finding a cure to cirrhosis

The unique liver function of a South American amphibian, Siphonops annulatus, could pave the way to finding a cure to the devastating liver condition cirrhosis, a new study published in the prestigious Journal of Anatomy reports.

6 Dec 2017

Moderate coffee consumption more likely to provide beneficial health outcomes

Drinking coffee is "more likely to benefit health than to harm it" for a range of health outcomes, say researchers in The BMJ today.

23 Nov 2017

Metabolic factors in conjunction with alcohol consumption increase risk of severe liver disease

A new study provides insights into the interaction between alcohol consumption and metabolic factors in predicting severe liver disease in the general population.

22 Nov 2017

Pioneering research project aims to develop better diagnostic tests for NAFLD

A pioneering European research project aims to lead to new diagnostic tests to assess patients with non-alcoholic fatty liver disease (NAFLD) and identify those most at risk for developing severe inflammation and liver scarring.

21 Nov 2017

Study identifies molecular pathway critical to development of fibrosis

A study led by investigators at Massachusetts General Hospital and University Health Network in Toronto has identified a molecular pathway that appears to be critical to the development of fibrosis - scarring and excessive tissue deposition that result from abnormal healing responses and can compromise the function of vital organs.

15 Nov 2017

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Research at the Southwest National Primate Research Center on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

7 Nov 2017

Fat hormone associated with NASH may be effective target for therapeutic intervention

The rising obesity epidemic has brought with it an army of maladies. One, in particular, is threatening to outpace many of the disorders that accompany obesity, in terms of occurrence and severity: nonalcoholic fatty liver disease.

7 Nov 2017

New review addresses aspects of nutrition in liver transplant candidates with cirrhosis

Poor nutrition is common in patients with liver failure, or cirrhosis, and it can lead to muscle wasting, weakness, fatigue, and worse outcomes before and after patients undergo liver transplantation.

26 Oct 2017

Direct‐acting antiviral therapy linked to 71% reduction in liver cancer risk

A new study presented this week at The Liver Meeting - held by the American Association for the Study of Liver Diseases - found that eradication of the hepatitis C virus induced by direct‐acting antiviral medications is associated with a 71 percent reduction in the risk of liver cancer.

20 Oct 2017

Study finds increasing health care costs for patients with alcoholic cirrhosis

Health care costs for privately insured patients with alcoholic cirrhosis are nearly twice that of non‐alcoholic cirrhosis patients in the United States, according to research presented this week at The Liver Meeting - held by the American Association for the Study of Liver Diseases.

20 Oct 2017

Study examines risk of using liver organs from hepatitis C positive donors

Use of liver organs from selected hepatitis C positive donors should be considered due to modest risk of hepatitis C transmission and the availability of safe and effective direct‐acting antiviral therapies, according to research presented this week at The Liver Meeting -; held by the American Association for the Study of Liver Diseases.

20 Oct 2017

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B virus‐related liver cancer.

20 Oct 2017

HCV screening or diagnosis could lower non‐prescribed opioid use

Research presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – shows people in treatment for opioid substance abuse significantly lowered their non‐prescribed opioid use after testing positive for hepatitis C virus.

20 Oct 2017

Liver cirrhosis mortality found to be greater than that of five major cancers

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that liver cirrhosis mortality is greater than that of five major cancers, implying the development of appropriate interventions to treat or prevent liver cirrhosis must be prioritized.

20 Oct 2017

Cirrhosis News and Research

Latest Cirrhosis News and Research

Long-term intake of sunflower, fish oils affects the liver

UT Southwestern oncologist highlights need to improve liver cancer screening rates

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

Drinking during late adolescence could be first step to liver problems in adulthood

Alcohol related ER visits on the rise especially among women, finds study

Emerging pharmacologic approach may inhibit NASH

Unique liver function of South American amphibian could pave way for finding a cure to cirrhosis

Moderate coffee consumption more likely to provide beneficial health outcomes

Metabolic factors in conjunction with alcohol consumption increase risk of severe liver disease

Pioneering research project aims to develop better diagnostic tests for NAFLD

Study identifies molecular pathway critical to development of fibrosis

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Fat hormone associated with NASH may be effective target for therapeutic intervention

New review addresses aspects of nutrition in liver transplant candidates with cirrhosis

Direct‐acting antiviral therapy linked to 71% reduction in liver cancer risk

Study finds increasing health care costs for patients with alcoholic cirrhosis

Study examines risk of using liver organs from hepatitis C positive donors

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

HCV screening or diagnosis could lower non‐prescribed opioid use

Liver cirrhosis mortality found to be greater than that of five major cancers

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Cirrhosis News and Research

Latest Cirrhosis News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in